HYATE:R
Baxter International Inc.
Application Filed: 2009-10-26
Trademark Application Details
CANCELLED – SECTION 71
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79076267 |
| Registration Number | 3892686 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Cancellation Code | F |
| Attorney Docket Number | 452301-8063 |
| Law Office Assigned | M80 |
| Employee Name | SAPPENFIELD, ANN ELIZA |
Timeline
| 2009-10-26 | Application Filed |
| 2010-10-05 | Published for Opposition |
| 2010-12-21 | Location: PUBLICATION AND ISSUE SECTION |
| 2010-12-21 | Trademark Registered |
| 2017-07-28 | Cancelled |
| 2017-07-28 | Status: Dead/Cancelled |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Baxter International Inc. |
| Address | One Baxter Parkway Deerfield, Il 60015 US |
| Legal Entity Type | |
| Legal Entity State | FR |
| Owner: | Baxter Healthcare SA |
| Address | Thurgauerstrasse 130 CH-8152 Glattpart (Opfikon) CH |
| Legal Entity Type | |
| Legal Entity State | FR |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations, namely, pharmaceutical preparations for use in the treatment of oncological diseases, pharmaceutical preparations for use in the treatment of neurological diseases, pharmaceutical preparations for use in the treatment of endocrine disorders, pharmaceutical preparations for use in the treatment of urological diseases, pharmaceutical preparations for use in the treatment of hormonal disorders, pharmaceutical preparations for the treatment of gastrointestinal bleeding disorders, pharmaceutical preparations for use in the treatment of haematological diseases, pharmaceutical preparations for use in the treatment of blood disorders, pharmaceutical preparations for use in the treatment of blood plasma disorders, pharmaceutical preparations for use in the treatment of coagulation disorders |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2009-12-24 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2009-12-30 | 2 NWOS I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2010-01-05 | 3 MAFR O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2010-01-30 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2010-02-10 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2010-02-11 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2010-02-11 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2010-02-11 | 8 RFCS P: |
| REFUSAL PROCESSED BY IB | 2010-03-05 | 9 RFNT P: |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2010-08-11 | 10 TROA I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2010-08-11 | 11 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2010-08-11 | 12 ARAA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2010-08-27 | 13 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2010-08-27 | 14 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2010-08-27 | 15 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2010-08-30 | 16 CNSA O:Outgoing Correspondence |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2010-08-30 | 17 PREV O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2010-10-05 | 18 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2010-10-05 | 19 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2010-12-21 | 20 R.PR A:Allowance for Publication |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2011-03-21 | 21 FICR P: |
| FINAL DISPOSITION PROCESSED | 2011-04-21 | 22 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2011-04-21 | 23 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2013-04-21 | 24 FINO P: |
| NEW REPRESENTATIVE AT IB RECEIVED | 2014-01-03 | 25 NREP P: |
| CHANGE OF OWNER RECEIVED FROM IB | 2014-01-03 | 26 CHLD M: |
| NEW REPRESENTATIVE AT IB RECEIVED | 2014-06-12 | 27 NREP P: |
| CANCELLED SECTION 71 | 2017-07-28 | 28 C71T O:Outgoing Correspondence |
| TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | 2018-03-28 | 29 INTR P: |
| GENERIC MADRID TRANSACTION CREATED | 2018-04-06 | 30 XXCR P: |
| GENERIC MADRID TRANSACTION SENT TO IB | 2018-04-06 | 31 XXSS O:Outgoing Correspondence |
| TOTAL INVALIDATION PROCESSED BY THE IB | 2018-04-27 | 32 INNT P: |
| DEATH OF INTERNATIONAL REGISTRATION | 2020-05-29 | 33 DETH P: |
| NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | 2020-05-29 | 34 DENC O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 HYATE:R 79076267 3892686 Dead/Cancelled |
Baxter International Inc. 2009-10-26 |
HYATE:R 79076267 3892686 Dead/Cancelled |
Baxter Healthcare SA 2009-10-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 